Multicentric and multifocal cancer: Whole-breast US in preoperative evaluation

Radiology

Volumn 214, Issue 1, 2000, Pages 59-66

  Berg, Wendie A ^a   Gilbreath, Patricia L ^a  

^a UNIVERSITY OF MARYLAND   (United States)

Author keywords

Breast neoplasms; Breast neoplasms, diagnosis; Breast radiography, comparative studies; Breast, MR; Breast, US

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CLASSIFICATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; ECHOMAMMOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; MAMMOGRAPHY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RADIODIAGNOSIS; TUMOR BIOPSY;

EID: 0033962169     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.214.1.r00ja2559     Document Type: Article

References (58)

1. Winchester DP, Cox JD. Standards for diagnosis and management of invasive breast carcinoma. American College of Radiology. American College of Surgeons. College of American Pathologists. Society of Surgical Oncology. CA Cancer J Clin 1998; 48:83-107.
2. Fisher B. Sounding board. Breast-cancer management: alternatives to radical mastectomy. N Engl J Med 1979; 301:326-328.
3. Lagios MD, Westdahl PR, Rose MR. The concept and implications of multicentricity in breast carcinoma. In: Sommers S, Rosen P, eds. Pathology annual. New York, NY: Appleton-Century-Crofts, 1981.
4. Holland R, Veling SHJ, Mravunac M, Hendriks JHCL. Histologic multifocality of Tis, T1-2 breast carcinomas: implications for clinical trials of breast-conserving surgery. Cancer 1985; 56:979-990.
5. Egan RL. Multicentric breast carcinomas: clinical-radiographic-pathologic whole organ studies and 10-year survival. Cancer 1982; 49:1123-1130.
6. Harms SE, Flamig DP, Hesley KL. Fat-suppressed three-dimensional MR imaging of the breast. RadioGraphics 1993; 13:247-267.
7. Orel SG, Schnall MD, Powell CM, et al. Staging of suspected breast cancer: effect of MR imaging and MR-guided biopsy. Radiology 1995; 196:115-122.
8. Panizza P, DeGaspari A, Vanzulli A, Rodighiero M, Camalori M, DelMaschio A. Accuracy of post-MR imaging second-look-sonography in previously undetected breast lesions (abstr). Radiology. 1997; 205(P):489.
9. American College of Radiology. Breast imaging reporting and data system. 3rd ed. Reston, Va: American College of Radiology, 1998.
10. Leopold KA, Recht A, Schnitt SJ, et al. Results of conservative surgery and radiation therapy for multiple synchronous cancers of one breast. Int J Radiat Oncol Biol Phys 1989; 16:11-16.
11. Kurtz JM, Jacquemier J, Amalric R, et al. Breast-conserving therapy for macroscopically multiple cancers. Ann Surg 1990; 212:38-44.
12. Hartsell WF, Recine DC, Griem KL, Cobleigh MA, Witt TR, Murthy AK. Should multicentric disease be an absolute contra-indication to the use of breast-conserving therapy? Int J Radiat Oncol Biol Phys 1994; 30:49-53.
13. Kurtz JM. How to predict the risk of local relapse in the preserved breast. Recent Results Cancer Res 1996; 140:263-272.
14. Fisher B, Anderson S, Redmond CK, Wolmark N, Wickerham DL, Cronin WM. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 1995; 333:1456-1461.
15. Dawson PJ. What is new in our understanding of multifocal breast cancer. Pathol Res Pract 1993; 189:111-116.
16. Fisher ER, Sass R, Fisher B, Gregorio R, Brown R, Wickerham L. Pathologic findings from the National Surgical Adjuvant Breast Project (protocol 6). II. Relation of local breast recurrence to multicentricity. Cancer 1986; 57:1717-1724.
17. Kurtz JM, Spitalier JM, Amalric R, et al. The prognostic significance of late local recurrence after breast-conserving therapy. Int J Radiat Oncol Biol Phys 1990; 18: 87-93.
18. Kraemer O, Andersen M, Siim E. Breast reconstruction and tissue expansion in irradiated versus not irradiated women after mastectomy. Scand J Plast Reconstr Surg Hand Surg 1996; 30:201-206.
19. Kurtz JM, Jacquemier J, Amalric R, et al. Is breast conservation after local recurrence feasible? Eur J Cancer 1991; 27:240-244.
20. Morrow M, Schmidt R, Hassett C. Patient selection for breast conservation therapy with magnification mammography. Surgery 1995; 118:621-626.
21. Burhenne HJ, Burhenne LW, Goldberg F, et al. Interval breast cancers in the screening mammography program of British Columbia: analysis and classification. AJR 1994; 162:1067-1071.
22. Robertson CL. A private breast imaging practice: medical audit of 25,788 screening and 1,077 diagnostic examinations. Radiology 1993; 187:75-79.
23. Kerlikowske K, Grady D, Barclay J, Sickles EA, Ernster V. Effect of age, breast density, and family history on the sensitivity of first screening mammography. JAMA 1996; 276:33-38.
24. Gordon PB, Goldenberg SL. Malignant breast masses detected only by ultrasound: a retrospective review. Cancer 1995; 76:626-630.
25. Kolb TM, Lichy J, Newhouse JH. Occult cancer in women with dense breasts: detection with screening US - diagnostic yield and tumor characteristics. Radiology 1998; 207:191-199.
26. Stavros AT, Thickman D, Rapp CL, Dennis MA, Parker SH, Sisney GA. Solid breast nodules: use of sonography to distinguish between benign and malignant lesions. Radiology 1995; 196:123-134.
27. Sickles EA. Periodic mammographic follow-up of probably benign lesions: results in 3,184 consecutive cases. Radiology 1991; 179:463-468.
28. Sickles EA. Nonpalpable, circumscribed, noncalcified solid breast masses: likelihood of malignancy based on lesion size and age of patient. Radiology 1994; 192: 439-442.
29. Gundry KR, Berg WA. Treatment issues and core needle breast biopsy: clinical context. AJR 1998; 171:41-49.
30. Rosenblatt R, Fineberg SA, Sparano JA, Kaleya RN. Stereotactic core needle biopsy of multiple sites in the breast: efficacy and effect on patient care. Radiology 1996; 201:67-70.
31. Liberman L, Dershaw DD, Rosen PP, Morris EA, Cohen MA, Abramson AF. Core needle biopsy of synchronous ipsilateral breast lesions: impact on treatment. AJR 1996; 166:1429-1432.
32. Yeatman TJ, Cantor AB, Smith TJ, et al. Tumor biology of infiltrating lobular carcinoma: implications for management. Ann Surg 1995; 222:549-559; discussion 559-561.
33. Mendelson EB, Harris KM, Doshi N, Tobon H. Infiltrating lobular carcinoma: mammographic patterns with pathologic correlation. AJR 1989; 153:265-271.
34. Newstead GM, Baute PB, Toth HK. Invasive lobular and ductal carcinoma: mammographic findings and stage at diagnosis. Radiology 1992; 184:623-627.
35. Helvie MA, Paramagul C, Oberman HA, Adler DD. Invasive lobular carcinoma: imaging features and clinical detection. Invest Radiol 1993; 28:202-207.
36. Butler RS, Venta LA, Wiley EL, Ellis RL, Dempsey PJ, Rubin E. Sonographic evaluation of infiltrating lobular carcinoma. AJR 1999; 172:325-330.
37. Harms SE, Flamig DP, Hesley KL. MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation. Radiology 1993; 187:493-501.
38. Orel SG, Schnall MD, LiVolsi VA, Troupin RH. Suspicious breast lesions: MR imaging with radiologic-pathologic correlation. Radiology. 1994; 190:485-493.
39. Gilles R, Guinebretiere JM, Lucidarme O, et al. Nonpalpable breast tumors: diagnosis with contrast-enhanced subtraction dynamic MR imaging. Radiology 1994; 191:625-631.
40. Boetes C, Barentsz JO, Mus RD, et al. MR characterization of suspicious breast lesions with a gadolinium-enhanced turbo-FLASH subtraction technique. Radiology 1994; 193:777-781.
41. Morris EA, Schwartz LH, Dershaw DD, van Zee KJ, Abramson AF, Liberman L. MR imaging of the breast in patients with occult primary breast carcinoma. Radiology 1997; 205:437-440.
42. Taillefer R. The role of 99mTc-sestamibi and other conventional radiopharmaceuticals in breast cancer diagnosis. Semin Nucl Med 1999; 29:16-40.
43. Helbich TH, Becherer A, Trattnig S, et al. Differentiation of benign and malignant breast lesions: MR imaging versus Tc-99m sestamibi scintimammography. Radiology 1997; 202:421-429.
44. Fenlon HM, Phelan N, Tierney S, Gorey T, Ennis JT. Tc-99m tetrofosmin scintigraphy as an adjunct to plain-film mammography in palpable breast lesions. Clin Radiol 1998; 53:17-24.
45. The W, Wilson ARM. The role of ultrasound in breast cancer screening: a consensus statement by the European Group for Breast Cancer Screening. Eur J Cancer 1998; 34:449-450.
46. Wanebo HJ, Senofsky GM, Fechner RE, Kaiser D, Lynn S, Paradies J. Bilateral breast cancer: risk reduction by contralateral biopsy. Ann Surg 1985; 201:667-677.
47. Haagensen CD. Diseases of the breast. 3rd ed. Philadelphia, Pa: Saunders, 1986; 450.
48. Fisher ER, Fisher B, Sass R, Wickerham L. Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol No 4). XI. Bilateral breast cancer. Cancer 1984; 54:3002-3011.
49. Rieber A, Merkle E, Bohm W, Brambs HJ, Tomczak R. MRI of histologically confirmed mammary carcinoma: clinical relevance of diagnostic procedures for detection of multifocal or contralateral secondary carcinoma. J Comput Assist Tomogr 1997; 21:773-779.
50. Lesser ML, Rosen PP, Kinne DW. Multicentricity and bilaterality in invasive breast carcinoma. Surgery 1982; 91:234-240.
51. Roubidoux MA, Helvie MA, Wilson TE, Lai NE, Paramagul C. Women with breast cancer: histologic findings in the contralateral breast. Radiology 1997: 203:691-694.
52. Cosgrove DO, Kedar RP, Bamber JC, et al. Breast diseases: color Doppler US in differential diagnosis. Radiology 1993; 189:99-104.
53. Raza S, Baum JK. Solid breast lesions: evaluation with power Doppler US. Radiology 1997; 203:164-168.
54. Mehta TS, Raza S. Power Doppler vascularity of breast cancer: does it correlate with node status or lymphatic vascular invasion. AJR 1999; 173:303-307.
55. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med 1991; 324:1-8.
56. Vassallo P, Wernecke K, Roos N, Peters PE. Differentiation between benign from malignant superficial lymphadenopathy: the role of high-resolution US. Radiology 1992; 183:215-220.
57. Parker SH, Jobe WE, Dennis MA, et al. US-guided automated large-core breast biopsy. Radiology 1993; 187:507-511.
58. Liberman L, Feng TL, Dershaw DD, Morris EA, Abramson AF. US-guided core breast biopsy: use and cost-effectiveness. Radiology 1998; 208:717-723.